Quest diagnostics reports first quarter 2022 financial results; raises guidance for full year 2022

First quarter revenues of $2.61 billion, down 4.0% from 2021 first quarter reported diluted earnings per share ("eps") of $2.92, down 15.6% from 2021; and adjusted diluted eps of $3.22, down 14.4% from 2021 base business revenues of $2.01 billion, up 6.3% from 2021 full year 2022 reported diluted eps now expected to be between $7.88 and $8.38; and adjusted diluted eps expected to be between $9.00 and $9.50 secaucus, n.j. , april 21, 2022 /prnewswire/ -- quest diagnostics incorporated (nyse: dgx), the world's leading provider of diagnostic information services, announced today financial results for the first quarter ended march 31, 2022.
DGX Ratings Summary
DGX Quant Ranking